Aldeyra Therapeutics Inc
NASDAQ:ALDX 4:00:00 PM EDT
Market Cap (Intraday) | 230.28M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $3.97 |
50-Day MA | $3.62 |
200-Day MA | $4.48 |
Aldeyra Therapeutics Inc Stock, NASDAQ:ALDX
131 Hartwell Avenue, Suite 320, Lexington, Massachusetts 02421
United States of America
Phone: +1.781.761.4904
Number of Employees: 10
Description
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.